Tuxarin ER regulatory update

FDA approved an NDA from Spriaso for Tuxarin ER codeine/chlorpheniramine to treat cough and cold. Spriaso is seeking a marketing partner for Tuxarin ER, an extended-release formulation of codeine, an ...